Evidence map›Paper›PMID 27274769›Full record

ArticleMolecular cytogenetics2016

Interstitial 6q21q23 duplication - variant of variable phenotype and incomplete penetrance or benign duplication?

Malgorzata I Srebniak, Laura J C M van Zutven, Florence Petit, Sonia Bouquillon, Ilse P J van Heel, Maarten F C M Knapen, Jerome M J Cornette, Andreas Kremer, Diane Van Opstal, Karin E M Diderich

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular cytogenetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Malgorzata I SrebniakDepartment of Clinical Genetics, Erasmus MC, Ee2475, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Laura J C M van ZutvenDepartment of Clinical Genetics, Erasmus MC, Ee2475, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Florence PetitDepartment of Clinical Genetics, University Hospital, Lille, France.
Sonia BouquillonDepartment of Cytogenetics, University Hospital, Lille, France.
Ilse P J van HeelDepartment of Clinical Genetics, Erasmus MC, Ee2475, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Maarten F C M KnapenDepartment of Obstetrics and Gynecology, subdivision Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam, The Netherlands ; Stichting Prenatale Screening Zuidwest Nederland, Wytemaweg 80, Na-1509, 3015, GE Na-1503 Rotterdam, The Netherlands.
Jerome M J CornetteDepartment of Obstetrics and Gynecology, subdivision Obstetrics and Prenatal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Andreas KremerDepartment of Bioinformatics Erasmus MC, Rotterdam, The Netherlands.
Diane Van OpstalDepartment of Clinical Genetics, Erasmus MC, Ee2475, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Karin E M DiderichDepartment of Clinical Genetics, Erasmus MC, Ee2475, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Erasmus University Rotterdam · NLErasmus MC · NLLille’s Cardiology Hospital · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChromosome 6q duplication syndrome is a chromosome abnormality associated with characteristic phenotypic features such as intellectual disability (ID), short stature, feeding difficulties, microcephaly, dysmorphic features (prominent forehead, downslanting palpebral fissures, flat nasal bridge, tented upper lip, micrognathia, short webbed neck) and joint contractures. Only a few cases of pure partial 6q trisomy have been published and the severity of the phenotype seems to depend on the breakpoint position. Unfortunately, most of these cases were identified using karyotyping or FISH, so breakpoints at the molecular level and thus gene content are not known. CASES PRESENTATION: We report the first two families with an interstitial 6q duplication identified by karyotyping where the gene content and breakpoints were characterized with microarray. In family 1, the 6q22.1q23.2 duplication was detected in a female patient with ID. In family 2, the 6q21q22.33 duplication was identified in a male fetus with multiple congenital malformations. In both families, the duplication seems to show phenotypic heterogeneity and in family 1 also incomplete penetrance suggesting the co-existence of an "additional hit" in affected patients. This "additional hit" was identified in the first family to be a microduplication in 16p11.2, a known susceptibility locus (SL) for neurodevelopmental disorders, that co-segregated with an abnormal phenotype in the affected family members.

conclusionsOur study shows that interstitial 6q21q23 duplication may represent a private variant that is benign, but may also contribute to developmental disorders of variable expressivity in a "multi-hit" model. Finding the "additional hit" within the family is therefore very important for genetic counseling and assessment of the CNV penetrance within the particular family.

Indexed as

16p11.2 microduplicationInterstitial 6q22.1q23.2 duplicationInterstitial duplication 6q21q22.33Second hit hypothesisSusceptibility locus

Identifiers

PMID27274769
PMCPMC4891832
OpenAlexW2409870086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.